351. Cathepsin S contributes to macrophage migration via degradation of elastic fibre integrity to facilitate vein graft neointimal hyperplasia.
- Author
-
Shi HT, Wang Y, Jia LX, Qin YW, Liu Y, Li HH, Qi YF, and Du J
- Subjects
- Animals, Cathepsins genetics, Disease Models, Animal, Hyperplasia pathology, Macrophages cytology, Mice, Mice, Inbred C57BL, Mice, Knockout, Myocytes, Smooth Muscle metabolism, Neointima metabolism, Neointima surgery, Signal Transduction physiology, Veins transplantation, Cathepsins metabolism, Cell Movement, Elastic Tissue pathology, Hyperplasia metabolism, Macrophages metabolism, Neointima pathology
- Abstract
Aims: Cathepsin S (Cat S) is a potent lysosomal protease that is secreted into the extracellular space and has been implicated in elastin and collagen degradation in diseases such as atherosclerosis. Elastin degradation plays an important role in vascular remodelling. However, the mechanism by which Cat regulates this process and its contribution to vein graft remodelling remains unclear., Methods and Results: Using a murine vein graft model, we examined the expression pattern of Cat family members. Expression of cathepsin genes was induced in vein grafts, with that of Cat S being the highest. Elevated Cat S expression was confirmed in both mouse and human vein grafts. To explore the role of Cat S, vein grafts were created between wild-type (WT) littermates and Cat S knockout (Cat S KO) mice. Knockout of Cat S in the recipients (vein(CatS-KO)-artery(CatS-KO) or vein(WT)-artery(CatS-KO)) significantly inhibited neointima formation and reduced the accumulation of macrophages and proliferation of smooth muscle cells in vein grafts. Knockout of Cat S preserved the elastic fibre integrity of vein grafts and inhibited the migration of macrophages across the elastin fibres., Conclusion: These results demonstrated that Cat S contributes to macrophage migration via degradation of elastic fibre integrity to facilitate neointima formation of vein grafts, which might provide a novel therapeutic target for preserving vein graft patency.
- Published
- 2014
- Full Text
- View/download PDF